| View |
|
DR-XY39434
|
Atorvastatin (As Calcium)
|
None
|
20 mg
|
Film-Coated Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
20 April 2021
|
10 May 2026
|
| View |
|
DR-XY39435
|
Metformin Hydrochloride
|
Neoform 500
|
500mg
|
Film-Coated Tablet
|
-
|
Sydenham Laboratories, Inc.
|
Philippines
|
-
|
02 February 2021
|
13 May 2026
|
| View |
|
DR-XY39441
|
Piperacillin (as Sodium ) + Tazobactam (as Sodium)
|
Tazocin
|
2 g/ 250 mg
|
Lyophilized Powder for I.V. Injection
|
Antibacterial (Penicillin-Beta-Lactamase Inhibitor Combination)
|
Wyeth Lederle S.r.L
|
Italy
|
Automatic Renewal
|
26 April 2021
|
30 June 2026
|
| View |
|
DR-XY39443
|
Ursodeoxycholic Acid
|
None
|
300 mg
|
Capsule
|
-
|
Amherst Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
14 July 2022
|
18 May 2026
|
| View |
DR-XY3945_PI_01.pdf
|
DR-XY3945
|
Flupentixol Decanoate
|
Fluanxol Depot
|
20mg/ mL
|
Solution for Injection (IM)
|
Neuroleptic
|
H. Lundbeck A/S
|
Denmark
|
Automatic Renewal
|
01 July 2021
|
30 July 2026
|
| View |
|
DR-XY39461
|
Clotrimazole
|
Dermotrim
|
10mg/g (1%)
|
Cream
|
-
|
Geofman Pharmaceuticals
|
Pakistan
|
-
|
07 May 2021
|
18 May 2026
|
| View |
|
DR-XY39464
|
Co-Amoxiclav
|
Clovimax
|
228.5 mg/5 mL
|
Powder for Suspension
|
Antibacterial
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
04 June 2021
|
17 May 2026
|
| View |
|
DR-XY39482
|
Warfedin
|
Warfarin (As Sodium)
|
2.5 mg
|
Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
20 May 2021
|
18 May 2026
|
| View |
|
DR-XY39483
|
Warfedin
|
Warfarin (As Sodium)
|
5 mg
|
Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
20 May 2021
|
18 May 2026
|
| View |
|
DR-XY39494
|
Atenolol
|
Myovasc
|
50mg
|
Film-Coated Tablet
|
Beta-adrenoceptor Blocker
|
Intas Pharmaceuticals Limited
|
India
|
Automatic Renewal
|
24 May 2023
|
19 May 2028
|
| View |
|
DR-XY39510
|
Pigrel
|
Clopidogrel(As Bisulfate)
|
75 mg
|
Film-Coated Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
20 May 2021
|
27 May 2026
|
| View |
|
DR-XY39536
|
Metformin (As Hydrochloride) / Glibenclamide
|
Diacom
|
500 mg/5 mg
|
Film-Coated Tablet
|
-
|
Hovid Berhad
|
Malaysia
|
-
|
08 February 2021
|
31 May 2026
|
| View |
|
DR-XY39547
|
TGP Zinc Gluconate
|
Zinc
|
10 mg (equivalent to 70 mg Zinc Gluconate)/5 mL
|
Syrup (Orange Flavor)
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
17 May 2021
|
01 June 2026
|
| View |
|
DR-XY39548
|
Zinc
|
Zinck
|
10 mg (equivalent to 70 mg Zinc Gluconate)/5 mL
|
Syrup (Lemon Flavor)
|
Mineral
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal [OTC]
|
28 April 2021
|
01 June 2026
|
| View |
|
DR-XY39564
|
Ranitidine (As Hydrochloride)
|
Ulci-Bloc
|
150mg
|
Film-Coated Tablet
|
H2 Receptor Blocker
|
Bal Pharma Ltd.
|
India
|
Automatic Renewal
|
09 March 2022
|
06 June 2027
|
| View |
|
DR-XY39579
|
Citicoline (As Sodium)
|
Cyline
|
1 g
|
Film-Coated Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
04 October 2022
|
08 June 2026
|
| View |
|
DR-XY39582
|
5% Dextrose In 0.3% Sodium Chloride
|
None
|
5 g/300 mg per 1000 mL
|
Solution For Intravenous Infusion
|
-
|
Shanxi Nuocheng Pharmaceutical Co., Ltd.
|
China
|
-
|
06 May 2021
|
08 June 2026
|
| View |
|
DR-XY39583
|
Balanced Multiple Maintenance Solution With 5% Dextrose (Adult)
|
Endusol-M
|
Formulation: Each 100 mL contains: Dextrose Monohydrate-5g Sodium Chloride-234mg Potassium Acetate-128mg Magnesium Acetate Tetrahydrate-32.20mg Sodium Metabisulfite-30mg (approx. 1.6 mmol/L)
Electrolytes in 1 L: Sodium-40 mmol Potassium-13 mmol Magnesium-1.5 mmol
Chloride-40 mmol Acetate-16 mmol
|
Solution For Intravenous Infusion
|
-
|
Shanxi Nuocheng Pharmaceutical Co., Ltd.
|
China
|
-
|
06 May 2021
|
08 June 2026
|
| View |
|
DR-XY39584
|
None
|
Peritoneal Dialysis Solution With 1.5% Dextrose
|
Formulation: Each 100 mL contains: Dextrose Monohydrate-1.5g Sodium Chloride-550mg Sodium Lactate Anhydrous-392mg Calcium Chloride Dihydrate-25.7mg Magnesium Chloride Hexahydrate-5.2mg Sodium Metabisulfite (approx. 3 meq/L)-30mg
Electrolytes in 1L: Sodium-129 mEq Calcium-3.5 mEq Magnesium-1.5 mEq Chloride-99 mEq Lactate-5 mEq
|
Solution for Intravenous Infusion
|
-
|
Shanxi Nuocheng Pharmaceutical Co., Ltd.
|
China
|
-
|
19 May 2021
|
08 June 2026
|
| View |
|
DR-XY39585
|
Balanced Multiple Replacement Solution With 5% Dextrose
|
Endusol-R
|
Formulation: Each 100 mL contains: Dextrose Monohydrate-5g Sodium Chloride-573mg Sodium Acetate Anhydrous-346mg Potassium Acetate-49mg Magnesium Acetate TetrahydratE-32.20mg Sodium Metabisulfite-30mg
Electrolytes in 1000 mL: Sodium-140 mmol Potassium-5 mmol Magnesium-1.5 mmol
Chloride-198 mmol Acetate-50 mmol
|
Solution For Iv Infusion
|
-
|
Shanxi Nuocheng Pharmaceutical Co., Ltd.
|
China
|
-
|
06 May 2021
|
08 June 2026
|